Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2015
August 2015, Vol 6, No 7
August 2015, Vol 6, No 7
Site of Service Significantly Impacts Cost of Chemotherapy
By
Dana Taylor
Economics & Value
,
Economics of Cancer Care
August 2015, Vol 6, No 7
Chicago, IL—An analysis of chemotherapy infusion by Aetna shows that approximately 75% of their patients still receive chemotherapy in a community oncology setting, suggested Michael A. Kolodziej, MD, National Medical Director for Oncology Strategy, Aetna at the 2015 American Society of Clinical Oncology meeting.
Read Article
Dissecting the Cost of Targeted Therapies in Oncology
By
Dana Taylor
Economics & Value
,
Economics of Cancer Care
,
Targeted Therapy
August 2015, Vol 6, No 7
Chicago, IL—It is not a surprise that targeted therapies are the main drivers of spending on anticancer drugs in the United States. At the 2015 American Society of Clinical Oncology meeting, researchers presented data from several major cancer centers about the cost of targeted therapies.
Read Article
The Missing Elements in Our Value-Based Care Discussions
By
Kevin Cast
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
August 2015, Vol 6, No 7
Although we all admire and support the efforts put forth by many experts to help quantify the “real” value of cancer medications, they still miss the mark in 2 dramatic ways.
Read Article
Addressing the Value of New Cancer Treatment Options Using the ASCO Model
By
Philip E. Johnson, MS, RPh, FASHP
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
August 2015, Vol 6, No 7
How can cancer care decisions be based on value? Two champions are starting to add science to this controversial discussion, which will eventually help all stakeholders make more informed decisions.
Read Article
ASCO’s Net Health Benefit: A Palliative Care Regimen Scores Higher than Active Treatment
By
Pamela Pelizzari, MPH
;
Bruce S. Pyenson, FSA, MAAA
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
August 2015, Vol 6, No 7
Medicare’s Oncology Care Model (OCM) proposes a partial shift in financial risk from Medicare to oncologists. This incentivizes oncologists to use higher-value, lower-cost services. Information such as the recently released American Society of Clinical Oncology (ASCO) framework to assess new cancer treatment options will likely garner keen interest among providers participating in the OCM or similar programs, to the benefit of providers, payers, and patients.
Read Article
ASCO’s Value Framework Promoting Accountability and Transparency
By
Joseph Morse
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
,
ASCO’s Value Framework
August 2015, Vol 6, No 7
The American Society of Clinical Oncology (ASCO) value framework essentially calls for accountability and transparency, which are qualities that are beneficial to providing complete care for patients and to improving positive patient outcomes.
Read Article
Emerging Tools for Assessing Value: Pros and Cons
By
Kirby J. Eng, RPh
Economics & Value
,
Value-Based Care
,
VBCC Perspectives
August 2015, Vol 6, No 7
The emergence of various tools for assessing value or, more to the point, drug costs—both direct and indirect—by leaders within the oncology and hematology community is highly commendable. Those of us on the managed care side of healthcare look forward to practical and meaningful tools in helping patients, providers, employers, and health plans navigate through the complexity of oncology drug therapy and drive better informed decision-making.
Read Article
Oncology News - August 2015
Oncology News
August 2015, Vol 6, No 7
Read Article
In the Literature - August 2015
In the Literature
August 2015, Vol 6, No 7
Read Article
By Looking Back, We Learn to Look Forward
By
Burt Zweigenhaft, PhD, D.Litt
From the Editor
,
Value Peer-spectives
August 2015, Vol 6, No 7
My personal journey to understanding and experiencing up close and personal the complexities in cancer care started some 20 years ago, when, like many of us, someone extremely close to you gets the dreaded news, “you have cancer.” For me, this was my mom. Regretfully, as we grow older, we all continue to hear this dreadful tale more frequently. These events have transformed my career over time to turn it into a mission—improving cancer care and seeking the cure.
Read Article
Page 2 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma